Helex is pioneering a paradigm shift in the treatment of chronic and rare kidney disorders by developing programmable non-viral lipid nanoparticle (LNP) therapeutics that deliver therapeutic cargo ...

Helex has raised $3.5m in an oversubscribed seed funding round spearheaded by pi Ventures to advance non-viral gene therapies for kidney diseases. The round saw participation from SOSV, Bluehill ...

Therapeutics Startup Helex Secures USD 3.5 Mn to Develop Targeted Kidney Treatments Helex, a therapeutics startup focused on genetic kidney diseases, has raised USD 3.5 million in a seed funding round ...

Biotechnology startup Helex on Thursday raised $3.5 million in a funding round led by pi Ventures, with participation from Bluehill Capital, SOSV, and a group of global investors, to advance the ...

Hyderabad- and US-based biotech startup Helex has raised $3.5 million in a seed round led by pi Ventures, with participation from Bluehill Capital, SOSV, and other global investors. The startup is ...

Founded in 2021, Helex operates in Health Tech industry. The company focuses on non-viral targeted delivery and genome editing, utilising its proprietary kidney ...

Helex, a US and India based therapeutics startup developing a new class of targeted medicines for genetic kidney diseases, today announced its oversubscribed $3.5 million Seed round, led by pi ...